NEW DELHI, Oct 31 (Reuters) - India’s Ranbaxy Laboratories (RANB.BO: Quote, Profile, Research) may get a strategic partner for its research unit that will be listed next year, and expects deals to sell products of global firms in emerging markets, its chief executive said.
